SG142127A1 - Vapor fraction from seeds of glycine max (l.) merr. and composition thereof - Google Patents
Vapor fraction from seeds of glycine max (l.) merr. and composition thereofInfo
- Publication number
- SG142127A1 SG142127A1 SG200306386-4A SG2003063864A SG142127A1 SG 142127 A1 SG142127 A1 SG 142127A1 SG 2003063864 A SG2003063864 A SG 2003063864A SG 142127 A1 SG142127 A1 SG 142127A1
- Authority
- SG
- Singapore
- Prior art keywords
- vapor fraction
- merr
- seeds
- glycine max
- composition
- Prior art date
Links
Landscapes
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
VAPOR FRACTION FROM SEEDS OF GLYCINE MAX (L.) MERR. AND COMPOSITION THEREOF The present invention mainly relates to a vapor fraction from seeds of Glycine max (L.) Merr. prepared by vaporizing a rude extract, and pharmaceutical composition thereof. The present invention also provides the use of the vapor fraction in treating skin injuries, dermatological disorders, stimulating cell regeneration, and stimulating hair growth.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SG200306386-4A SG142127A1 (en) | 2003-09-12 | 2003-09-12 | Vapor fraction from seeds of glycine max (l.) merr. and composition thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SG200306386-4A SG142127A1 (en) | 2003-09-12 | 2003-09-12 | Vapor fraction from seeds of glycine max (l.) merr. and composition thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
SG142127A1 true SG142127A1 (en) | 2008-05-28 |
Family
ID=39426718
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG200306386-4A SG142127A1 (en) | 2003-09-12 | 2003-09-12 | Vapor fraction from seeds of glycine max (l.) merr. and composition thereof |
Country Status (1)
Country | Link |
---|---|
SG (1) | SG142127A1 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20130072577A1 (en) * | 2009-08-17 | 2013-03-21 | Alexander ChinHak Chong | Vaporized Medicants and Methods of Use |
US9770408B2 (en) | 2009-08-17 | 2017-09-26 | Chong Corporation | Vaporized medicants and methods of use |
US10098918B2 (en) | 2009-08-17 | 2018-10-16 | Chong Corporation | Vaporized medicants and methods of use |
US10758582B2 (en) | 2009-08-17 | 2020-09-01 | Xten Capital Group, Inc. | Vaporized medicants and methods of use |
US10918684B2 (en) | 2009-08-17 | 2021-02-16 | Cqens Technologies, Inc. | Vaporized medicants and methods of use |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61275224A (en) * | 1985-05-29 | 1986-12-05 | Sunstar Inc | Collagenase-inhibiting agent |
JPH0925225A (en) * | 1995-05-09 | 1997-01-28 | Sansho Seiyaku Co Ltd | Skin external agent and production of active component for the agent |
JPH1029911A (en) * | 1996-07-16 | 1998-02-03 | Osaka Yakuhin Kenkyusho:Kk | Cosmetic material composition |
JP2001151636A (en) * | 1999-09-09 | 2001-06-05 | Mitsuko Sawada | Pack for cosmetic and production thereof |
US6555118B1 (en) * | 2001-02-22 | 2003-04-29 | Sarfaraz K Niazi | Pharmaceutical preparation for the treatment of topical wounds and ulcers |
-
2003
- 2003-09-12 SG SG200306386-4A patent/SG142127A1/en unknown
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61275224A (en) * | 1985-05-29 | 1986-12-05 | Sunstar Inc | Collagenase-inhibiting agent |
JPH0925225A (en) * | 1995-05-09 | 1997-01-28 | Sansho Seiyaku Co Ltd | Skin external agent and production of active component for the agent |
JPH1029911A (en) * | 1996-07-16 | 1998-02-03 | Osaka Yakuhin Kenkyusho:Kk | Cosmetic material composition |
JP2001151636A (en) * | 1999-09-09 | 2001-06-05 | Mitsuko Sawada | Pack for cosmetic and production thereof |
US6555118B1 (en) * | 2001-02-22 | 2003-04-29 | Sarfaraz K Niazi | Pharmaceutical preparation for the treatment of topical wounds and ulcers |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20130072577A1 (en) * | 2009-08-17 | 2013-03-21 | Alexander ChinHak Chong | Vaporized Medicants and Methods of Use |
US8962040B2 (en) * | 2009-08-17 | 2015-02-24 | Alexander ChinHak Chong | Vaporized medicants and methods of use |
US9283180B2 (en) | 2009-08-17 | 2016-03-15 | Chong Corporation | Vaporized medicants and methods of use |
US9770408B2 (en) | 2009-08-17 | 2017-09-26 | Chong Corporation | Vaporized medicants and methods of use |
US10098918B2 (en) | 2009-08-17 | 2018-10-16 | Chong Corporation | Vaporized medicants and methods of use |
US10610483B2 (en) | 2009-08-17 | 2020-04-07 | Chong Corporation | Vaporized medicants and methods of use |
US10758582B2 (en) | 2009-08-17 | 2020-09-01 | Xten Capital Group, Inc. | Vaporized medicants and methods of use |
US10918684B2 (en) | 2009-08-17 | 2021-02-16 | Cqens Technologies, Inc. | Vaporized medicants and methods of use |
US11622985B2 (en) | 2009-08-17 | 2023-04-11 | Cqens Technologies, Inc. | Vaporized medicants and methods of use |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA05008617A (en) | Uses of anti-insulin-like growth factor i receptor antibodies. | |
WO2005000245A3 (en) | Compositions and methods for increasing telomerase activity | |
TW201129368A (en) | Peptides used in the treatment and/or care of the skin, mucous membranes and/or hair and its use in cosmetic or pharmaceutical compositions | |
WO2004069190A3 (en) | Combination therapy for treating protein deficiency disorders | |
WO2005044179A3 (en) | Formulations containing astragalus extracts and uses thereof | |
TW200637522A (en) | Skin treatment articles and methods | |
WO2005000215A3 (en) | Methods for treating pain | |
AU2003301190A1 (en) | Administration of capsaicinoids | |
MXPA05006269A (en) | Use of an extract of decaffeinated coffee beans in the preparation of a composition intended to stimulate the sebaceous function of the skin by oral administration. | |
WO2005065269A3 (en) | Compositions and method for decreasing the appearance of skin wrinkles | |
WO2005081742A3 (en) | Testosterone oral dosage formulations and associated methods | |
EP1658853A4 (en) | Remedy for internal administration against cranial nerve diseases containing mesenchymal cells as the active ingredient | |
WO2010085039A3 (en) | Noggin-derived peptide and use thereof | |
TW200801031A (en) | Steroid nitrooxyderivatives | |
WO2002064088A3 (en) | Pharmaceutical composition for the treatment of alopecia | |
WO2012014081A8 (en) | Use of a composition comprising a peptidic fava bean extract for the stimulation of hair growth | |
MXPA05010708A (en) | Pharmaceutical composition comprising an immunosuppressant for use in the treatment of skin diseases. | |
PT1414473E (en) | ORAL ADMINISTRATION COMPOSITIONS FOR THE TREATMENT OF CABELUDE LEATHER DISTURBLES | |
TW200724150A (en) | Plant extracts for treating skin disorders and enhancing healing of wounds for diabetics patients | |
SG142127A1 (en) | Vapor fraction from seeds of glycine max (l.) merr. and composition thereof | |
CN105362105A (en) | Mask with effects of skin metabolism improving and aging delaying, and preparation method thereof | |
TW200505466A (en) | Vapor fraction from seeds of glycine max (l.) merr. and composition thereof | |
DE60310742D1 (en) | EXTRACT WITH ANTITUMORAL AND ANTITOXIC EFFECT | |
WO2005009456A3 (en) | Use of peptidic conjugates for preparing compositions for alopecia preventive and curative treatment | |
MY148508A (en) | Vapor fraction from seeds of glycine max (l.) merr. and compositions thereof |